Cefotaxime
Cefotaxime, Claforan (cefotaxime) is a small molecule pharmaceutical. Cefotaxime was first approved as Cefotaxime on 1982-01-01. It is used to treat acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, and bacterial skin diseases amongst others in the USA.
| Trade Name | Cefotaxime, Claforan |
|---|---|
| Common Name | Cefotaxime |
| Indication | acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, bacterial skin diseases, bacteroides infections, clostridium infections, escherichia coli infections, fusobacterium infections, gonorrhea, haemophilus infections, infectious bone diseases, klebsiella infections, pelvic inflammatory disease, peritonitis, proteus infections, pseudomonas infections, salmonella infections, sepsis, serratia infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections |
| Drug Class | Cephalosporins |
